You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
22 June 2026 - Biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ: LABT) announced on Monday that it has secured a new composition of matter patent from IP Australia covering its Bisphosphocin compounds, strengthening its global intell...
22 June 2026 - Gene therapy company Genprex Inc (NASDAQ: GNPX) disclosed on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering the use of its Reqorsa gene therapy (quaratusugene ozep...
22 June 2026 - French biotech company Transgene (Euronext Paris:TNG) announced on Monday that it has initiated a randomised Phase 1 trial of TG4070, an individualised neoantigen therapeutic vaccine, in combination with nivolumab for the adjuvant trea...
22 June 2026 - Replicate Bioscience, a clinical-stage company developing novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, announced on Friday that it has been awarded a...
22 June 2026 - Arletta Pharma Solutions, a Netherlands-based biopharmaceutical company specialising in innovative therapies for women diagnosed with Female Sexual Disorders (FSD), announced on Friday the appointment of Steve van Os, MD, as chief medi...
22 June 2026 - Kither Biotech Pty Ltd and Kither Biotech srl, an Italy-based clinical-stage biopharmaceutical group of companies developing innovative therapies for respiratory diseases, announced on Friday the successful completion of their Phase 1 ...
22 June 2026 - The Novo Nordisk Foundation, a philanthropic enterprise foundation created by Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO), announced on Friday that it is funding a new pan-European initiative to accelerate dr...